{"id":"W3168125055","doi":"10.1200/jco.2021.39.15_suppl.4556","title":"Randomized phase Ib study to evaluate safety, pharmacokinetics and therapeutic activity of simlukafusp α in combination with atezolizumab ± bevacizumab in patients with unresectable advanced/ metastatic renal cell carcinoma (RCC) (NCT03063762).","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Peptidase Inhibition and Analysis","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Roche","keywords":"Medicine; Bevacizumab; Atezolizumab; Internal medicine; Renal cell carcinoma; Oncology; Phases of clinical research; Urology; Gastroenterology; Cancer; Surgery; Chemotherapy; Immunotherapy; Nivolumab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001666565,0.001307821,0.002670683,0.0003603948,0.0003511928,0.00110524,0.0009560789,0.001243221,0.006485018],"category_scores_gemma":[0.001154879,0.0006593896,0.001071677,0.0004778723,0.001012414,0.0009916367,0.0004228034,0.00296631,0.001326408],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001420783,"about_ca_system_score_gemma":0.00211903,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0011737,"about_ca_topic_score_gemma":0.003152644,"domain_scores_codex":[0.9994115,0.0002779523,0.00003643434,0.0001279491,0.00004964213,0.00009647582],"domain_scores_gemma":[0.9990645,0.0001242907,0.0002199421,0.00008096088,0.00005209381,0.0004582688],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9426625,0.01903578,0.002083804,0.0002691436,0.0005882803,0.00007124226,0.00006295771,0.0007938032,0.009005638,0.0001311013,0.001198089,0.02409762],"study_design_scores_gemma":[0.7926995,0.201159,0.002749696,0.00001381797,0.0002828362,0.0000849664,0.00002085243,0.0005377596,0.0009294564,0.0001473824,0.001362176,0.00001255204],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9867225,0.001753506,0.0009191515,0.0004336302,0.0002987126,0.005430701,0.001624947,0.0001493246,0.00266736],"genre_scores_gemma":[0.9848,0.001063673,0.00215821,0.001071155,0.0002724274,0.004860105,0.002357772,0.00003636515,0.003380272],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006485018,"threshold_uncertainty_score":0.02169454,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06200820168896527,"score_gpt":0.4398082610935457,"score_spread":0.3778000594045804,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}